{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:28:16Z","timestamp":1784392096357,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Osteoarthritis (OA) is the most common degenerative joint disease, characterized by chronic pain and articular cartilage damage. Hip OA is characterized by the progressive breakdown of articular cartilage within the hip, particularly the hip joints ball and socket structure, Hip OA leads to joint pain, stiffness and causes functional limitations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To analyse the effectiveness of intra-articular corticosteroids (IA CS) use against other injection therapies for the symptomatic management of hip OA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>PROSPERO registered\u2014CRD42024526221. Medline, Embase, Scopus and Web of Science were searched for trials. Inclusion Criteria: Adults with symptomatic hip OA, randomised trials for treatment of hip OA with IA injection methods. Studies must involve comparators and the outcome measure must include a measurement of pain such as Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) or the visual analogue scale (VAS). Cochrane risk of bias and JBI critical appraisal tools assessed risk of bias. RevMan was used for creation of statistical figures within the meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Data extracted in the systematic review presented improvements on pain, function, stiffness, and overall scores using WOMAC and VAS scales. However, data from the meta-analysis indicates that there is no statistical significance (significance is a p value\u2009&lt;\u20090.05) between corticosteroids and placebo or hyaluronic acid (HA). Meta-analyses produced <jats:italic>p<\/jats:italic> values of 0.05 when comparing CS and placebo WOMAC pain scores at 2\u00a0months, CS and HA overall WOMAC at 6\u00a0months\u2014<jats:italic>p<\/jats:italic> value of 0.46. WOMAC stiffness and function scores between CS and placebo at 2\u00a0months\u2014p value of 0.05 and 0.08, thus statistically insignificant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This meta-analysis shows that IA corticosteroid injections for hip OA don\u2019t provide statistically significant symptomatic improvement for patients compared to placebo. Showing the urgent need to assess other therapies in hip OA treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12891-025-08666-0","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:04:49Z","timestamp":1747281889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pain management of hip osteoarthritis with corticosteroids vs injection therapies: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Euan","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"8666_CR1","unstructured":"GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508\u201322."},{"issue":"1","key":"8666_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","volume":"10","author":"L Tong","year":"2022","unstructured":"Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L, et al. Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res. 2022;10(1):60.","journal-title":"Bone Res"},{"issue":"1","key":"8666_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10787-023-01223-y","volume":"32","author":"WW Buchanan","year":"2024","unstructured":"Buchanan WW, Kean CA, Kean WF, Rainsford KD. Osteoarthritis Inflammopharmacology. 2024;32(1):13\u201322.","journal-title":"Osteoarthritis. Inflammopharmacology."},{"issue":"2","key":"8666_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00001648-199903000-00013","volume":"10","author":"SA Oliveria","year":"1999","unstructured":"Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology. 1999;10(2):161\u20136.","journal-title":"Epidemiology"},{"issue":"8","key":"8666_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","volume":"17","author":"RF Loeser","year":"2009","unstructured":"Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17(8):971\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"8666_CR6","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1249\/MSS.0000000000001944","volume":"51","author":"VB Kraus","year":"2019","unstructured":"Kraus VB, Sprow K, Powell KE, Buchner D, Bloodgood B, Piercy K, et al. Effects of Physical Activity in Knee and Hip Osteoarthritis: A Systematic Umbrella Review. Med Sci Sports Exerc. 2019;51(6):1324\u201339.","journal-title":"Med Sci Sports Exerc"},{"key":"8666_CR7","first-page":"F1000 Faculty R","volume":"9","author":"S Gr\u00e4ssel","year":"2020","unstructured":"Gr\u00e4ssel S, Muschter D. Recent advances in the treatment of osteoarthritis. 2020;9:F1000 Faculty Rev-325.","journal-title":"Recent advances in the treatment of osteoarthritis."},{"key":"8666_CR8","unstructured":"National Clinical Guideline Centre (UK). Osteoarthritis: Care and Management in Adults. London: National Institute for Health and Care Excellence (UK); 2014."},{"issue":"3","key":"8666_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5312\/wjo.v5.i3.351","volume":"5","author":"E Ayhan","year":"2014","unstructured":"Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351\u201361.","journal-title":"World J Orthop"},{"issue":"5","key":"8666_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00002281-199909000-00016","volume":"11","author":"P Creamer","year":"1999","unstructured":"Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999;11(5):417\u201321.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"8666_CR11","first-page":"18","volume":"29","author":"TD Rozental","year":"2000","unstructured":"Rozental TD, Sculco TP. Intra-articular corticosteroids: an updated overview. Am J Orthop (Belle Mead NJ). 2000;29(1):18\u201323.","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"2","key":"8666_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00063030-199809020-00002","volume":"9","author":"M Ostergaard","year":"1998","unstructured":"Ostergaard M, Halberg P. Intra-articular corticosteroids in arthritic disease: a guide to treatment. BioDrugs. 1998;9(2):95\u2013103.","journal-title":"BioDrugs"},{"issue":"2","key":"8666_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","volume":"11","author":"JA Nagy","year":"2008","unstructured":"Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11(2):109\u201319.","journal-title":"Angiogenesis"},{"issue":"10","key":"8666_CR14","first-page":"CD005328","volume":"2015","author":"P J\u00fcni","year":"2015","unstructured":"J\u00fcni P, Hari R, Rutjes AWS, Fischer R, Silletta MG, Reichenbach S, et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015;2015(10):CD005328.","journal-title":"Cochrane Database Syst Rev."},{"key":"8666_CR15","unstructured":"National Institute for Health and Care Excellence. NICE Guideline 226 https:\/\/www.nice.org.uk\/guidance\/ng226 . 2022. Osteoarthritis in over 16s: diagnosis and management."},{"issue":"15","key":"8666_CR16","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/bjsports-2022-105898","volume":"57","author":"Q Weng","year":"2023","unstructured":"Weng Q, Goh SL, Wu J, Persson MSM, Wei J, Sarmanova A, et al. Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthritis: a network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(15):990\u20136.","journal-title":"Br J Sports Med"},{"issue":"5","key":"8666_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/11207000221107225","volume":"33","author":"ML Angotti","year":"2023","unstructured":"Angotti ML, Burnett RA, Khalid S, Terhune EB, Della Valle CJ. Intra-articular corticosteroids associated with increased risk of total hip arthroplasty at 5 years. Hip Int. 2023;33(5):800\u20135.","journal-title":"Hip Int"},{"issue":"4","key":"8666_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8666_CR19","first-page":"CD005328","volume":"2","author":"N Bellamy","year":"2006","unstructured":"Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005328.","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"8666_CR20","doi-asserted-by":"publisher","first-page":"232596711558116","DOI":"10.1177\/2325967115581163","volume":"3","author":"C Wernecke","year":"2015","unstructured":"Wernecke C, Braun HJ, Dragoo JL. The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review. Orthop J Sports Med. 2015;3(5):2325967115581163.","journal-title":"Orthop J Sports Med"},{"issue":"19","key":"8666_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","volume":"317","author":"TE McAlindon","year":"2017","unstructured":"McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2017;317(19):1967\u201375.","journal-title":"JAMA"},{"issue":"3","key":"8666_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1148\/radiol.2019190341","volume":"293","author":"AJ Kompel","year":"2019","unstructured":"Kompel AJ, Roemer FW, Murakami AM, Diaz LE, Crema MD, Guermazi A. Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Safe as We Thought? Radiology. 2019;293(3):656\u201363.","journal-title":"Radiology"},{"key":"8666_CR23","unstructured":"NHS England. National Health Service 2019\/20, https:\/\/www.england.nhs.uk\/publication\/2019-20-national-cost-collection-data-publication\/. 2021. NHS - 2019\/20 National Cost Collection Data Publication."},{"key":"8666_CR24","doi-asserted-by":"crossref","unstructured":"Wood G, Neilson J, Cottrell E, Hoole SP, Guideline Committee. Osteoarthritis in people over 16: diagnosis and management-updated summary of NICE guidance. BMJ. 2023;380:24.","DOI":"10.1136\/bmj.p24"},{"key":"8666_CR25","doi-asserted-by":"crossref","unstructured":"Adami G, Saag KG, Chapurlat RD, Gua\u00f1abens N, Haugeberg G, Lems WF, et al. Balancing benefits and risks in the era of biologics. Ther Adv Musculoskelet Dis. 2019;11:1759720X19883973.","DOI":"10.1177\/1759720X19883973"},{"issue":"1","key":"8666_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/11539760-000000000-00000","volume":"11","author":"T Iannitti","year":"2011","unstructured":"Iannitti T, Lodi D, Palmieri B. Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drugs R D. 2011;11(1):13\u201327.","journal-title":"Drugs R D"},{"issue":"2","key":"8666_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/ar623","volume":"5","author":"LW Moreland","year":"2003","unstructured":"Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003;5(2):54\u201367.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"8666_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2165\/00002512-200724080-00002","volume":"24","author":"DD Waddell","year":"2007","unstructured":"Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging. 2007;24(8):629\u201342.","journal-title":"Drugs Aging"},{"issue":"12","key":"8666_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/ard.2008.092015","volume":"67","author":"W Zhang","year":"2008","unstructured":"Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67(12):1716\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8666_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/BMR-2009-0207","volume":"22","author":"D Diracoglu","year":"2009","unstructured":"Diracoglu D, Vural M, Baskent A, Dikici F, Aksoy C. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis. J Back Musculoskelet Rehabil. 2009;22(1):1\u20139.","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"5","key":"8666_CR31","first-page":"951","volume":"33","author":"RJ Petrella","year":"2006","unstructured":"Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33(5):951\u20136.","journal-title":"J Rheumatol"},{"key":"8666_CR32","unstructured":"Day R, Brooks P, Conaghan PG, Petersen M, Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31(4):775\u201382."},{"issue":"2","key":"8666_CR33","first-page":"99","volume":"59","author":"JJ Wu","year":"1997","unstructured":"Wu JJ, Shih LY, Hsu HC, Chen TH. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei). 1997;59(2):99\u2013106.","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"2","key":"8666_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1063-4584(05)80024-X","volume":"1","author":"M Dougados","year":"1993","unstructured":"Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993;1(2):97\u2013103.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4 Suppl","key":"8666_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1091581809337738","volume":"28","author":"LC Becker","year":"2009","unstructured":"Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, et al. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol. 2009;28(4 Suppl):5\u201367.","journal-title":"Int J Toxicol"},{"issue":"5","key":"8666_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1249\/JSR.0b013e31822ed1b4","volume":"10","author":"JG Divine","year":"2011","unstructured":"Divine JG, Shaffer MD. Use of viscosupplementation for knee osteoarthritis: an update. Curr Sports Med Rep. 2011;10(5):279\u201384.","journal-title":"Curr Sports Med Rep"},{"issue":"6","key":"8666_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.7326\/0003-4819-136-6-200203190-00011","volume":"136","author":"DE Moerman","year":"2002","unstructured":"Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med. 2002;136(6):471\u20136.","journal-title":"Ann Intern Med"},{"issue":"1","key":"8666_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1523\/JNEUROSCI.19-01-00484.1999","volume":"19","author":"M Amanzio","year":"1999","unstructured":"Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19(1):484\u201394.","journal-title":"J Neurosci"},{"key":"8666_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.psych.59.113006.095941","volume":"59","author":"DD Price","year":"2008","unstructured":"Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565\u201390.","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"8666_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/2229-3485.106383","volume":"4","author":"U Gupta","year":"2013","unstructured":"Gupta U, Verma M. Placebo in clinical trials. Perspect Clin Res. 2013;4(1):49\u201352.","journal-title":"Perspect Clin Res"},{"issue":"2","key":"8666_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.joca.2005.09.007","volume":"14","author":"E Qvistgaard","year":"2006","unstructured":"Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage. 2006;14(2):163\u201370.","journal-title":"Osteoarthritis Cartilage"},{"issue":"366","key":"8666_CR42","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898.","journal-title":"BMJ"},{"key":"8666_CR43","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142.","DOI":"10.1002\/14651858.ED000142"},{"issue":"3","key":"8666_CR44","first-page":"494","volume":"21","author":"TH Barker","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023;21(3):494\u2013506.","journal-title":"JBI Evid Synth"},{"issue":"1","key":"8666_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.crad.2011.07.040","volume":"67","author":"R Young","year":"2012","unstructured":"Young R, Harding J, Kingsly A, Bradley M. Therapeutic hip injections: is the injection volume important? Clin Radiol. 2012;67(1):55\u201360.","journal-title":"Clin Radiol"},{"issue":"377","key":"8666_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068446","volume":"6","author":"Z Paskins","year":"2022","unstructured":"Paskins Z, Bromley K, Lewis M, Hughes G, Hughes E, Hennings S, et al. Clinical effectiveness of one ultrasound guided intra-articular corticosteroid and local anaesthetic injection in addition to advice and education for hip osteoarthritis (HIT trial): single blind, parallel group, three arm, randomised controlled trial. BMJ. 2022;6(377): e068446.","journal-title":"BMJ"},{"issue":"11","key":"8666_CR47","first-page":"2265","volume":"31","author":"B Kullenberg","year":"2004","unstructured":"Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S. Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip? J Rheumatol. 2004;31(11):2265\u20138.","journal-title":"J Rheumatol"},{"issue":"7","key":"8666_CR48","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1002\/art.22739","volume":"56","author":"RGW Lambert","year":"2007","unstructured":"Lambert RGW, Hutchings EJ, Grace MGA, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2007;56(7):2278\u201387.","journal-title":"Arthritis Rheum"},{"key":"8666_CR49","doi-asserted-by":"publisher","first-page":"117954412211189","DOI":"10.1177\/11795441221118920","volume":"15","author":"A Aksoy","year":"2022","unstructured":"Aksoy A, Gulcu A, Tuna MM, Aslan A. Radiologically Guided Versus Blinded Intra-articular Injection in Patients With Hip Osteoarthritis: A Retrospective Comparative Study. Clin Med Insights Arthritis Musculoskelet Disord. 2022;15:11795441221118920.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"6","key":"8666_CR50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1590\/1413-785220202806240075","volume":"28","author":"RMU De","year":"2020","unstructured":"De RMU, Gurgel HMC, Ocampos GP, De CGC, Frucchi R, Pailo AF, et al. IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20. Acta Ortop Bras. 2020;28(6):280\u20136.","journal-title":"Acta Ortop Bras"},{"issue":"2","key":"8666_CR51","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.arth.2020.08.036","volume":"36","author":"K Jurgensmeier","year":"2021","unstructured":"Jurgensmeier K, Jurgensmeier D, Kunz DE, Fuerst PG, Warth LC, Daines SB. Intra-articular Injections of the Hip and Knee With Triamcinolone vs Ketorolac: A Randomized Controlled Trial. J Arthroplasty. 2021;36(2):416\u201322.","journal-title":"J Arthroplasty"},{"issue":"2","key":"8666_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3810\/psm.2010.06.1781","volume":"38","author":"AI Spitzer","year":"2010","unstructured":"Spitzer AI, Bockow BI, Brander VA, Yates JW, MacCarter DK, Gudger GK, et al. Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study. Phys Sportsmed. 2010;38(2):35\u201347.","journal-title":"Phys Sportsmed"},{"issue":"7","key":"8666_CR53","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2106\/00004623-200307000-00003","volume":"85","author":"SS Leopold","year":"2003","unstructured":"Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am. 2003;85(7):1197\u2013203.","journal-title":"J Bone Joint Surg Am."},{"issue":"12","key":"8666_CR54","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/art.24925","volume":"61","author":"RR Bannuru","year":"2009","unstructured":"Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(12):1704\u201311.","journal-title":"Arthritis Rheum"},{"key":"8666_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijsu.2017.01.087","volume":"39","author":"WW He","year":"2017","unstructured":"He WW, Kuang MJ, Zhao J, Sun L, Lu B, Wang Y, et al. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis. Int J Surg. 2017;39:95\u2013103.","journal-title":"Int J Surg"},{"issue":"2","key":"8666_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3892\/etm.2014.2131","volume":"9","author":"F Wang","year":"2015","unstructured":"Wang F, He X. Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: A meta-analysis. Exp Ther Med. 2015;9(2):493\u2013500.","journal-title":"Exp Ther Med"},{"issue":"7444","key":"8666_CR57","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/bmj.38039.573970.7C","volume":"328","author":"B Arroll","year":"2004","unstructured":"Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 2004;328(7444):869.","journal-title":"BMJ"},{"issue":"7","key":"8666_CR58","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/PHM.0000000000001384","volume":"99","author":"M Saltychev","year":"2020","unstructured":"Saltychev M, Mattie R, McCormick Z, Laimi K. The Magnitude and Duration of the Effect of Intra-articular Corticosteroid Injections on Pain Severity in Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Am J Phys Med Rehabil. 2020;99(7):617\u201325.","journal-title":"Am J Phys Med Rehabil"},{"key":"8666_CR59","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 30285357."},{"issue":"2","key":"8666_CR60","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/MS9.0000000000000106","volume":"85","author":"FA Idres","year":"2023","unstructured":"Idres FA, Samaan M. Intra-articular platelet-rich plasma vs. corticosteroid injections efficacy in knee osteoarthritis treatment: a systematic review. Ann Med Surg (Lond). 2023;85(2):102\u201310.","journal-title":"Ann Med Surg (Lond)."},{"issue":"1","key":"8666_CR61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13018-020-01753-z","volume":"15","author":"A Elksni\u0146\u0161-Finogejevs","year":"2020","unstructured":"Elksni\u0146\u0161-Finogejevs A, Vidal L, Peredistijs A. Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up. J Orthop Surg Res. 2020;15(1):257.","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"8666_CR62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2217\/rme-2018-0161","volume":"14","author":"J Freitag","year":"2019","unstructured":"Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A, et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regenerative Med. 2019;14(3):213\u201330.","journal-title":"Regenerative Med"},{"issue":"6","key":"8666_CR63","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/sctm.18-0122","volume":"8","author":"WS Lee","year":"2019","unstructured":"Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial. Stem Cells Transl Med. 2019;8(6):504\u201311.","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"8666_CR64","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/medicina57111193","volume":"57","author":"O Dulic","year":"2021","unstructured":"Dulic O, Rasovic P, Lalic I, Kecojevic V, Gavrilovic G, Abazovic D, et al. Bone Marrow Aspirate Concentrate versus Platelet Rich Plasma or Hyaluronic Acid for the Treatment of Knee Osteoarthritis. Medicina (Kaunas). 2021;57(11):1193.","journal-title":"Medicina (Kaunas)."},{"issue":"3","key":"8666_CR65","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/03635465211072554","volume":"50","author":"AW Anz","year":"2022","unstructured":"Anz AW, Plummer HA, Cohen A, Everts PA, Andrews JR, Hackel JG. Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 2 Years: A Prospective Randomized Trial. Am J Sports Med. 2022;50(3):618\u201329.","journal-title":"Am J Sports Med"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-08666-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:03:43Z","timestamp":1747285423000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-08666-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8666"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-08666-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is not applicable for consent to participate. This study is not applicable for ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study is not applicable for consent for publication as it has no participants. Both authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"473"}}